RA Capital Nexus Fund II, 10% Owner: AN2 Therapeutics ANTX Buy · Filed 23/08/22

Trade details

Type: Insider buy
Amount: $16,000,002
Shares · price: 1,777,778 sh · $9.00 a share
Held after: 5,135,683 sh
Stock: AN2 Therapeutics ANTX
Person: RA Capital Nexus Fund II10% Owner
Trade date: 23/08/18
Filed: 23/08/22
Days to filing: 4 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +52.9%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/19~23/09/17

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06